Navigation Links
Comparing Psoriasis Treatments

A new study shows two common treatments for psoriasis -- methotrexate and cyclosporine -- are equally effective in relieving symptoms of the disease. //

Researchers in Amsterdam studied nearly 90 patients with moderate-to-severe psoriasis. Half of the patients were given methotrexate, and the other half were treated with cyclosporine. Researchers evaluated the side effects and effectiveness of each drug. They also recorded the time patients were in remission and assessed their quality of life. None of the participants had previously been treated with methotrexate or cyclosporine.

Results of the study show the overall response rate for both drugs was more than 90 percent. Seventeen patients in the methotrexate group and 14 patients in the cyclosporine group reached nearly complete remission. Twenty-six patients in the methotrexate group and 30 patients in the cyclosporine group achieved partial remission. However, after 16 weeks of treatment, no significant difference in overall effectiveness was seen between the two groups.

More than 100 patients in the methotrexate group and more than 150 patients in the cyclosporine group reported side effects. More patients in the methotrexate group reported nausea, and patients in the cyclosporine group were more likely to report headaches. There were no significant reported differences in quality of life between the two groups.

Authors of the study say the overall effectiveness of methotrexate is similar to that of cyclosporine. They conclude, "Differences between the treatments in terms of side effects, long-term adverse effects, ease of administration, and costs can be used to guide treatment decisions in individual cases."
'"/>




Page: 1

Related medicine news :

1. Comparing Breast surgery techniques
2. Comparing heart disease treatments
3. New and unique treatment for Psoriasis patients
4. Psoriasis Increases Cancer Risk
5. Help for Psoriasis
6. Managing Patients With Psoriasis
7. Effective Treatment Option For Psoriasis
8. Smoking Aggravates Psoriasis
9. Remicade Emerges as a Treatment for Patients Suffering From Psoriasis Disorder
10. Short-Term Topical Corticosteroid May Offer Relief for Certain Type of Psoriasis
11. Psoriasis raises risk for heart attack

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Comparing Psoriasis Treatments

(Date:11/30/2009).... Centers for Disease Control and Prevention estim...d States are infected with HIV/AIDS. New research ...ny of those infected are minorities and do not hav...national strategy to facilitate education and prev...ons. , The research, which analyzed 90,000 HIV p...
(Date:11/30/2009)... Author of "My Two-Year Old E... children who love to eat everything. , ... have a picky eater in your house? Do you find yo...Three new short online videos – one focusing... the third on answers for real-life parents’...
(Date:11/30/2009)... , ENGLEWOOD, Colo., Nov. 30 ...entation discussing what "culture of safety" means...osium presentation, "Creating a Culture of Safety...professionals discussing their experiences with cu...of safety in pharmacy and the role of technology i...
(Date:11/30/2009)..., KALAMAZOO, Mich., Nov. 30 /PRNewswire-FirstCall...unced a definitive agreement to acquire privately... leader in the reprocessing and remanufacturing of...s of the agreement, Stryker will acquire Ascent He... transaction. The closing is conditioned on the ex...
(Date:11/30/2009)... N.C. Finding and treating a tumor without distur...the most effective therapies can be invasive and h...enter have devised a way they might deliver the ri...ules, called aptamers, which specifically bind to ...l of aptamers in a rodent with liver cancer until ...
Breaking Medicine News(10 mins):Health News:Research highlights need for national HIV strategy 2Health News:New Videos Help Parents of Picky Eaters 2Health News:New Videos Help Parents of Picky Eaters 3Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 2Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 3Health News:First live targeting of tumors with RNA-based technology 2Health News:First live targeting of tumors with RNA-based technology 3
...ss Scripts, Inc. (Nasdaq: ESRX ) announced that ...ealth Care Conference on May 19, 2009 at 10:10 a.m... , This presentation will also be broadcast via th...ws Media Player is needed to listen to the Webcast...
... 13 /PRNewswire-Asia/ -- Winner Medical Group Inc....the "Company"), today,reported unaudited financial...9. The Company,s results are detailed in its form ...eased by 15.31% over the second quarter of, ...
...vity of Cystathionase is reduced in rodent models ...and impaired generation of hydrogen sulphide, two ... and increased intrahepatic resistance. , In the p...ligand to carbon tetrachloride treated mice protec...
...ing a hallmark of hereditary hemochromatosis , is ... or non-alcoholic steatohepatitis and non-alcoholi...has investigated the link between ferritin and ste...present a risk factor for steatosis and clinical r...
...n pump inhibitor which powerfully suppresses gastr...ronic use in gastroesophageal reflux disease. Lans... unresponsive to conventional medication as a symp...e is impossible. Discontinuation of lansoprazole r...
...ial Day Is Declared "Don,t Fry Day" to Encourage S... As millions of Americans prepare to enjoy the gr...uncil on Skin Cancer Prevention reminds everyone t... rise significantly, at a rate faster than any of ...
Other Medicine News:Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 2Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 3Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 4Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 5Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 6Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 7Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 8Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 9Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 10Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 11Health News:Farnesoid X receptor regulates cystathionase 2Health News:Chronic diarrhea unresponsive to conventional medication: Are you taking lansoprazole? 2Health News:The National Council on Skin Cancer Prevention Encourages Everyone to Protect Your Skin Today and Every Day 2Health News:The National Council on Skin Cancer Prevention Encourages Everyone to Protect Your Skin Today and Every Day 3
(Date:11/30/2009)...ewswire/ -- StemCyte, Inc. concluded an exclusive ...mia Sinica, the National Laboratory of Taiwan, for...erty (IP) related to the treatment of Chronic Stro...red by a team led by Professor John Lin, MD, PhD a...urrently the exclusive collaborator with StemCyte ...
(Date:11/30/2009)...30 eHealthSource.com launched the ...o products approved for Flexible Spending Account ...ite is also the first to exclusively carry value-b...s up to 75 percent on everyday healthcare needs. ...are headaches - high costs and complexity," says e...
(Date:11/30/2009)...30 Health Robotics today announced...s and product specifications,for a new and revolut...ition", a new key component of its i.v. Room of th... (Booth # 114). , "I look forward to see ...s blueprints and to find out if TPNstation appears...
Breaking Medicine Technology:StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 3Landmark project to map genomics of complex ant systems 9188 1Landmark project to map genomics of complex ant systems 9188 2European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 1European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 2Pioneer of Digital Place Based Media Joins World 26apos 3Bs Leading Blood Pressure and Health Kiosk Manufacturer 51199 1Pioneer of Digital Place Based Media Joins World 26apos 3Bs Leading Blood Pressure and Health Kiosk Manufacturer 51199 2
...BANE, Calif.--(BUSINESS WIRE)--Jul 2, 2007 - Terci...y management will make an,investment community pre...rowth Opportunities Conference at the Mandarin Ori...7 at 4:00 p.m. Eastern,time (1:00 p.m. Pacific tim...ill be available,via the Internet by visiting the ...
...RIDGE, Mass.--(BUSINESS WIRE)--Jul 2, 2007 - ViaCe...D. Beer, President and,Chief Executive Officer of ...tivities and product pipeline at the C.E. Unterber... on Tuesday, July,10, 2007 at 3:00 p.m. at the Man... webcast of the presentation will be available on,...
Other Medicine Technology:
...ed to be your best option for cannulation using a ...of curve shapes during the procedure with a single...andle mechanism in the desired shape to address ea... Stable, Versatile Workstation. Inject contrast th...
Attain LV Leads
Hancock® II Aortic Bioprostheses
Medtronic Aortic Punches
Medicine Products: